Cyprus Vaccine Industry Outlook 2024 - 2028

See how Cyprus Vaccine performed compared to key markets.

Key Market Indicators

**Cyprus Maintains Steady Vaccination Coverage, Eyes Increased Vaccine Imports** By 2028, Cyprus is projected to maintain a vaccination coverage rate of 96% for children aged one year, unchanged from the current 96% in 2023. This stability reflects a consistent trend since 1985, with the market showing a slight annual decrease of 0.2 percentage points. Meanwhile, the country's vaccine imports are on an upward trajectory. By 2028, Cyprus is expected to import vaccines worth approximately $14 million, up from $12.5 million in 2023. This represents an average annual growth rate of 1.7% since 1994, during which time the demand for vaccines has increased by 0.9% year on year. In contrast, Cypriot vaccine exports have seen a dramatic rise. In 2018, exports surged to $2,730, a significant leap from $265 in 2017, marking an extraordinary increase of nearly 929% year on year.

Cyprus Vaccine Market Data and Forecasts

How much will Cyprus Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Cyprus
Forecast: Import of Vaccines for Human Use to Cyprus
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Cyprus
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Cyprus
Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in Cyprus

Other Top Countries about Vaccine